Related Experiment Video

Updated: May 29, 2026

Gastrointestinal Motility Monitor (GIMM)
08:15

Gastrointestinal Motility Monitor (GIMM)

Published on: December 1, 2010

Truncated IRAG variants modulate cGMP-mediated inhibition of human colonic smooth muscle cell contraction

Alexander von Werder1, Martina Mayr, Günter Schneider

  • 1II. Medizinische Klinik, Technische Universität München, Ismaninger Strasse 22, Munich, Germany.

American Journal of Physiology. Cell Physiology
|August 26, 2011
PubMed

Insights

Nitric oxide (NO) signaling in colonic smooth muscle is modulated by IRAG variants. Alternative splicing of the IRAG gene generates diverse protein isoforms impacting calcium signaling and smooth muscle relaxation.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Physiology

Background:

  • Nitric oxide (NO) relaxes colonic smooth muscle via cGMP/cGKI signaling.
  • This pathway involves phosphorylation of IRAG, inhibiting calcium signaling.
  • The structural and functional diversity of human IRAG/MRVI1 is not fully understood.

Purpose of the Study:

  • To analyze the structure and function of the human IRAG/MRVI1 gene.
  • To investigate the role of IRAG variants in colonic smooth muscle function.
  • To understand how alternative splicing impacts NO/cGKI signaling.

Main Methods:

  • Analysis of human IRAG/MRVI1 gene structure.
  • Identification of alternative first exon variants and promoters.
  • Investigation of tissue-specific alternative splicing events.
  • Functional assays on colonic smooth muscle cells.

Main Results:

  • Four unique first exon variants of the IRAG gene were identified across diverse human tissues.
  • Tissue-specific alternative splicing generates numerous IRAG mRNA variants, including truncated proteins.
  • COOH-terminally truncated IRAG variants counteract cGMP-mediated inhibition of calcium transients and smooth muscle relaxation.
  • These truncated IRAG variants are widely expressed in human tissues.

Conclusions:

  • The human IRAG gene exhibits complex alternative splicing, producing functionally distinct proteins.
  • IRAG variants, particularly truncated forms, act as negative modulators of NO/cGKI-dependent signaling.
  • Posttranscriptional processing of IRAG plays a crucial role in regulating smooth muscle function.

More Related Videos

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology10:26

Bladder Smooth Muscle Strip Contractility as a Method to Evaluate Lower Urinary Tract Pharmacology

Published on: August 18, 2014

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease05:08

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease

Published on: March 1, 2022

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...